Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2009 New trial record.